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CLINICAL AND POPULATION STUDIES
Novel Genetic Locus Influencing Retinal Venular 
Tortuosity Is Also Associated With Risk of 
Coronary Artery Disease
Abirami Veluchamy, Lucia Ballerini, Veronique Vitart, Katharina E. Schraut, Mirna Kirin, Harry Campbell, Peter K. Joshi,  
Devanjali Relan, Sarah Harris, Ellie Brown, Suraj S. Vaidya, Baljean Dhillon, Kaixin Zhou, Ewan R. Pearson,  
Caroline Hayward, Ozren Polasek, Ian J. Deary, Thomas MacGillivray, James F. Wilson, Emanuele Trucco,  
Colin N.A. Palmer,* Alexander S.F. Doney*
OBJECTIVE: The retina may provide readily accessible imaging biomarkers of global cardiovascular health. Increasing evidence 
suggests variation in retinal vascular traits is highly heritable. This study aimed to identify the genetic determinants of retinal 
vascular traits.
APPROACH AND RESULTS: We conducted a meta-analysis of genome-wide association studies for quantitative retinal vascular traits 
derived using semi-automatic image analysis of digital retinal photographs from the GoDARTS (Genetics of Diabetes Audit and 
Research in Tayside; N=1736) and ORCADES (Orkney Complex Disease Study; N=1358) cohorts. We identified a novel genome-
wide significant locus at 19q13 (ACTN4/CAPN12) for retinal venular tortuosity (TortV), and one at 13q34 (COL4A2) for retinal 
arteriolar tortuosity (TortA); these 2 loci were subsequently confirmed in 3 independent cohorts (Ntotal=1413). In the combined 
analysis of discovery and replication cohorts, the lead single-nucleotide polymorphism in ACTN4/CAPN12 was rs1808382 
(βs.d.=-0.109; SE=0.015; P=2.39×10-
13) and in COL4A2 was rs7991229 (βs.d.=0.103; SE=0.015; P=4.66×10-
12). Notably, the 
ACTN4/CAPN12 locus associated with TortV is also associated with coronary artery disease, heart rate, and atrial fibrillation.
CONCLUSIONS: Genetic determinants of retinal vascular tortuosity are also linked to cardiovascular health. These findings 
provide a molecular pathophysiological foundation for the use of retinal vascular traits as biomarkers for cardiovascular 
diseases.
VISUAL OVERVIEW: An online visual overview is available for this article.
Key Words: atrial fibrillation ◼ biomarkers ◼ cardiovascular diseases ◼ genome-wide association study ◼ heart rate ◼ retina
Retinal vascular traits can be readily measured non-invasively from fundus images, and changes in these traits have been linked to a number of clini-
cal conditions associated with vascular health, includ-
ing cardiovascular disease,1,2 stroke,3 hypertension,4 and 
neurodegenerative disease.5 The association between 
retinal vascular calibers and cardiovascular disease has 
been reported in numerous studies, and structural varia-
tion in retinal vasculature could predict cardiovascular 
risk.6–8 More recently, deep learning applied to retinal 
images has been successfully used to predict cardiovas-
cular risk factors and outcomes.9 Whereas this potentially 
powerful approach indicated that vascular regions of the 
retina appeared important, it cannot provide a molecular 
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pathoetiological basis for the link between retinal vascu-
lature and cardiovascular disease.
Population-based studies have demonstrated a sig-
nificant genetic component to variation in retinal blood 
vessel width.10 Evidence suggests that retinal vascular 
tortuosity, a potentially important vascular parameter, is 
also associated with a range of cardiovascular risk fac-
tors.11,12 Heritability estimates for retinal arterial tortuosity 
range from 50% to 82% and 21% for retinal venular tor-
tuosity,10,13 indicating a substantial genetic contribution to 
the variation in these parameters. Recent genome-wide 
association studies (GWAS) found a number of loci for 
the more widely investigated retinal traits, central retinal 
vein equivalent (CRVE)14–16 and central retinal arteriolar 
equivalent (CRAE)14–16 as well as retinal image-derived 
optic disk morphology parameters.17
To our knowledge, no studies have performed a 
genome-wide scan on retinal vascular tortuosity traits. 
Understanding the molecular genetic architecture of 
retinal tortuosity traits would provide a molecular patho-
physiological basis linking retinal microvascular features 
with systemic vascular pathology. We, therefore, per-
formed a sufficiently powered GWAS to identify genetic 
variants influencing the retinal vascular tortuosity traits; 
arteriolar tortuosity (TortA), maximum TortA (TortAmax), 
venular tortuosity (TortV), and maximum TortV (TortVmax). 
We also examined other previously investigated retinal 
parameters, including CRAE, CRVE, arteriole-to-venule 
ratio (AVR), as well as the nonvascular optic disc radius 
(ODradius). We have investigated whether any of the 
significant variants associated with tortuosity traits are 
also associated with cardiovascular-related outcomes in 
the previously published GWAS results. There is ample 
evidence indicating that increased resting heart rate is 
linked to various cardiovascular events and associated 
with the increased risk of plaque rupture in coronary 
atherosclerosis patients.18,19 Therefore, we also checked 
whether there is any association between TortV-asso-
ciated variants with heart rate in independent samples 
from United Kingdom Biobank.
SUBJECTS AND METHODS
Data analysis, methods, and all other supporting materials are 
available in the online-only Data Supplement document. The 
data that support the findings of this study are available to the 
researchers from the corresponding author upon request.
Study Participants
Participants in the discovery phase of this study were obtained 
from 2 independent cohorts, the GoDARTS (Genetics of 
Diabetes Audit and Research in Tayside20) and the ORCADES 
(Orkney Complex Disease Study).21 Three independent cohorts 
of individuals of European ancestry were used at the replication 
stage, including the Lothian Birth Cohort 1936 (LBC1936),22 
the Croatia-Korčula, and Croatia-Split study. Detailed descrip-
tions of each cohort are presented in the online-only Data 
Supplement note.
Retinal Vascular Parameter Measurement
Standard digital retinal photographs used for diabetes melli-
tus retinal screening were obtained from the clinical record of 
Nonstandard Abbreviations and Acronyms
AF atrial fibrillation
AVR arteriole-to-venule ratio
CAD coronary artery disease
CRAE retinal arteriolar equivalent
CRVE central retinal vein equivalent
eQTL expression quantitative trait loci
GoDARTS  Genetics of Diabetes Audit and 
Research in Tayside
GWAS Genome-wide association studies
HDL high-density lipoprotein
LBC1936 Lothian Birth Cohort 1936
LDL low-density lipoprotein
ODradius optic disc radius
ORCADES Orkney Complex Disease Study
SNP single-nucleotide polymorphism
QC quality control
TortA arteriolar tortuosity
TortV venular tortuosity
Highlights
• Emerging evidence indicates that retinal tortuosity 
traits are associated with vascular health and highly 
heritable. However, the genetic architecture of reti-
nal vascular tortuosity has not been investigated.
• By using a meta-analysis of genome-wide associa-
tion studies, we found a novel association at 19q13 
(ACTN4/CAPN12) for retinal venular tortuosity 
(TortV), and one at 13q34 (COL4A2) for retinal arte-
riolar tortuosity (TortA) at discovery stage and vali-
dated in 3 independent cohorts.
• In-silico look-ups indicate that the significant asso-
ciations between lead single-nucleotide polymor-
phisms at 19q13 and coronary artery disease, 
cardiovascular vascular risk factors, atrial fibrillation, 
and heart rate. Colocalization eQTL study (expres-
sion quantitative trait loci) found CAPN12 as most 
likely to be a causal gene for TortV in heart and 
blood vessel tissues.
• Our findings highlight genetic impacts on TortV, and 
their association with cardiovascular disease and 
may provide a molecular pathophysiological founda-
tion for the use of retinal vascular traits as biomark-
ers for cardiovascular diseases.
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patients with type 2 diabetes mellitus in GoDARTS. A total of 
1744 images (661 images from the GoDARTS data set 1 and 
1083 images from GoDARTS data set 2) were selected for 
analysis after quality control (QC). Similarly, 1595 individual’s 
retinal images from ORCADES were used for this study after 
QC. The Vascular Assessment and Measurement Platform for 
Images of Retina 3.1, semi-automatic software, was used to 
measure retinal vascular traits in fundus images (Figure I in 
the online-only Data Supplement) from both GoDARTS and 
ORCADES. Standard protocols were followed to measure 
the retinal vessel parameters,23 including CRAE, CRVE, AVR, 
ODradius, TortA, TortAmax, TortV, and TortVmax (online-only 
Data Supplement). Tortuosity mean values were normalized 
by natural log transformation for association analysis (Figure 
II in the online-only Data Supplement). Smaller values indicate 
straighter vessels. After quality assessment and processing, a 
total of 644, 387, and 382 individuals’ retinal fundus images 
from the LBC1936, Croatia- Korčula, and Croatia-Split cohorts, 
respectively, were selected for the analysis. In these cohorts, 
retinal tortuosity traits were quantified using SIVA v3.124 
(Singapore I Vessels Assessment), semi-automated software, 
and normalized by natural log transformation for association 
analysis (online-only Data Supplement).
Genotyping, QC, and Imputation
GoDARTS participants were genotyped using the Affymetrix 6.0 
(n=927) and Illumina Human Omni Express (n=809) platforms. 
ORCADES samples were genotyped with either the Illumina 
HumanHap300 bead chip (n=890) or the Illumina Omni1M 
(n=304) or Illumina Omni Express bead chips (n=1073). 
Genotype data quality was assessed and imputed on the basis 
of 1000 Genome Projects reference panel. Imputed genotypes 
for 658, 1078, 1358 individuals from the GoDARTS data set 
1, GoDARTS data set 2, and ORCADES cohorts, respectively, 
were used for the three independent GWAS analysis.
LBC1936 samples were genotyped using the Illumina 
Human 610Quad BeadChip. A total of 1398 participants from 
the 2 independent Croatian replication cohorts were avail-
able for the analysis, and subjects were genotyped on differ-
ent genotyping platforms including Illumina CNV370v1 and 
CNV370-Quadv3 for Croatia-Korčula (n=378), and Illumina 
CNV370-Quadv3 and IlluminaOmniExpressExome-8v1_A for 
Croatia-Split (n=376). More details on QC, imputation, and pro-
cessing can be found in the online-only Data Supplement.
Statistical Analyses
We performed association analyses with each data set from 
GoDARTS separately for each of the 8 retinal traits using 
SNPTEST V2.525 linear regression assuming an additive 
genetic model, adjusting for 3 ancestry principal components, 
age at eye examination, and gender. Association analysis in 
ORCADES was performed using linear mixed modeling to 
account for relatedness and assuming an additive genetic 
model, adjusting for 3 ancestry principal components, age and 
gender, using the mmscore function in ProbABEL.26 Then, we 
performed the meta-analysis using a fixed-effects model in 
GWAMA27 with the QC filtered GWAS summary results (impu-
tation quality score >0.4 and minor allele frequency >0.03) 
from the GoDARTS and ORCADES. Manhattan plots, Quantile-
Quantile plots, and forest plots were generated using in-built R 
scripts, and metafor—R package. Regional plots were gener-
ated using the Locus Zoom tool.28
Conditional analyses were performed in SNPTEST v2.5 
using the genome-wide significant loci in the COL4A2 region, 
conditioned on the lead single-nucleotide polymorphism (SNP) 
(rs56399312). In addition, this newly discovered locus was 
conditioned on previously reported genome-wide significant 
SNPs (rs4773144,29 rs11617955,30 and rs951520331) asso-
ciated with coronary artery disease (CAD). We performed an 
association test with an additive model adjusted for age, gen-
der, and the first 3 principal components ancestry in the dia-
betes mellitus cohort (GoDARTS) using 759 samples without 
any cardiovascular events before the retinal screening date. We 
investigated the in-silico functional effects of the sentinel vari-
ants for each retinal vascular traits using various bioinformatics 
databases.32–37 Details can be found in the online-only Data 
Supplement.
The top 3 SNPs (P≤1.07×10−07) near ACTN4, TMEM132D, 
and COL4A2 from the discovery stage for the tortuosity traits 
were taken forward for examination in 3 replication cohorts of 
European ancestry. In the LBC1936 cohort, association anal-
yses were performed for arterial and venular tortuosity traits 
using linear regression model adjusting for age, sex, and 3 
ancestry principal components, using mach2qtl. Similarly, in the 
Croatia—Split, and Korčula cohorts, association analyses were 
performed for each trait separately using linear mixed models 
implemented in the hglm R package, accounting for kinships 
derived using the gkin function of the GenABEL package.38
Summary association statistics for lead SNPs associated 
with TortA and TortV from the 2 discovery and 3 replication 
cohorts were combined and effect estimates from each cohort 
were presented in the forest plots using metafor—R package. 
Because of the variability in the β values and SE between the 
discovery and replication studies arising from different mea-
surement algorithms, we standardized the effect estimates 
(using Cohen d) from each of the individual study cohorts. 
Cohen d is a scale-free interpretation which provides a stan-
dardized effect size measurement between the studies.39 In this 
study, Cohen d was calculated by the effect estimate divided 
by the SD.
In-Silico Look-Ups of the Novel Variants for 
Clinical Outcomes
To investigate the association of the lead SNPs for TortA, and 
TortV with cardiovascular outcomes, we performed in-silico 
look-ups using summary association results from the Coronary 
Artery Disease Genome-wide Replication and meta-analysis 
plus C4D consortium,29 Global Lipid Genetics Consortium 
analysis40, and International consortium for blood pressure 
GWAS analysis.41 A recent study reported the association of 
ACTN4 locus with heart rate.42 To examine whether the lead 
SNPs associated with TortV in ACTN4 were also associated 
with heart rate, we checked the linkage disequilibrium (r2>0.8) 
between our SNPs and the index SNP (rs11083475) for 
heart rate in that study. Furthermore, we investigated the asso-
ciation of these SNPs with pulse rate in UK Biobank data.43 
Additionally, we explored the relationship between the TortV-
associated variants with atrial fibrillation (AF) using the sum-
mary statistics data from a recent large-scale meta-analysis 
of GWAS of AF.44 To identify the potential causal/target gene 
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for TortV-associated variants, colocalization analysis was per-
formed eCAVIAR.45 Details of these studies and online in-silico 
functional annotation resources have been described in the 
online-only Data Supplement on methods.
RESULTS
Meta-Analysis of Discovery GWAS
The characteristics of the discovery study cohorts and 
overall study design can be found in Table I in the online-
only Data Supplement and Figure 1. We combined 
the summary GWAS results from the GoDARTS and 
ORCADES cohorts for each trait using a fixed-effect 
meta-analysis, which overall showed no evidence of 
excessive amount of false-positive associations (genomic 
inflation factor of 0.99). Table II in the online-only Data 
Supplement presents the results from the meta-analysis 
and independent cohort GWAS analysis. Manhattan plots, 
Quantile-Quantile plots, and regional plots are shown in 
Figures 2 and 3 and Figures III through V in the online-
only Data Supplement, respectively.
This analysis revealed one genome-wide significant 
(P<5×10−8) SNP, rs56399312, associated with TortA at 
13q34, in COL4A2 with moderate heterogeneity (I2=0.50; 
β=0.182, SE=0.032, P=2.70×10−8), and another SNP 
rs9515212 near COL4A2 that was just below the thresh-
old for genome-wide significance (β=0.151, SE=0.028, 
P=8.59×10−8). Conditional analysis on the lead SNP 
indicated that these are not independent signals (Table III 
in the online-only Data Supplement). Two genome-wide 
significant SNPs were associated with TortV, at 19q13 in 
ACTN4 (lead SNP rs1808382; β=−0.123, SE=0.022, 
P=1.55×10−8; no heterogeneity, I2=0.00), and at 12q24.33 
near TMEM132D (lead SNP rs73157566; β=−0.294, 
SE=0.054, P=4.07×10−8; low heterogeneity, I2=0.10); 
these associations at both these loci have not been 
reported previously with any retinal vascular parameters.
Moreover, we replicated 3 loci out of 8 previously 
reported loci for CRVE14,16 but did not replicate any of 
the previously reported SNPs associated with CRAE.15 
Finally, we replicated a previously reported genome-
wide significant locus for ODradius at 10q21.3 near 
PBLD (lead SNP rs61854835; β=−3.840, SE=0.575, 
P=4.06×10−11) and confirmed a number of other loci 
for this trait17,46–48 (Table IV in the online-only Data 
Supplement).
Replication of Novel Associations With Vessel 
Tortuosity in Independent Cohorts
As candidates to carry forward for replication, we selected 
3 lead SNPs from both loci (total 6 SNPs) (ACTN4/
CAPN12 andTMEM132D) for TortV and COL4A2 for 
TortA that reached significance P≤1.07×10−07 and had 
Figure 1. Study Design. 
Natural log-transformed data—TortA, TortAmax, TortV, TortVmax, u is the genetic value for each subject under a random-effects model, 
covariance amongst subjects assumed to be proportionate to the genomic relationship matrix. All Croatia indicates Croatia island of Korcula, 
Croatia-Split; AVR, arteriole-to-venule ratio; CRAE, Central Retinal Arteriolar Equivalent; CRVE, Central Retinal Venular Equivalent; GoDARTS, 
Genetics of Diabetes Audit and Research in Tayside; LBC1936, Lothian Birth Cohorts 1936; ODradius, Optic Disc Radius; ORCADES, 
Orkney Complex Disease Study; PC, principal components; TortA, retinal arteriolar tortuosity; TortAmax, maximum retinal arteriolar tortuosity; 
TortV, retinal venular tortuosity; and TortVmax, maximum retinal arteriolar tortuosity.
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similar effect size and direction across the discovery 
cohorts. The characteristics of the replication cohorts are 
presented in Table V in the online-only Data Supplement.
Two TortA-associated SNPs, rs7991229, and 
rs9515212 in COL4A2 reached nominal significance 
(P<0.05) in the LBC1936, Croatian cohorts. P values were 
significant after multiple testing in stage 2 and combined 
analyses (based on 2 independent tests). The lead SNP 
(rs56399312) from discovery stage did not reach signifi-
cant P value in the LBC1936 but had similar effect size 
and direction. Two TortV-associated SNPs, rs1808382 
and rs3786835 in ACTN4/CAPN12 reached suggestive 
significance (P<1×10−04) in the combined analysis of repli-
cation cohorts whereas rs73157566 near TMEM132D did 
not replicate. Table contains the summary statistics from 
replication cohorts and meta-analysis of these cohorts.
Meta-Analysis of Discovery and Replication 
Cohorts
In the overall meta-analysis, SNPs at 13q34, COL4A2 
(TortA) and 19q13, ACTN4 (TortV) display genome-wide 
Figure 2. Manhattan plots for meta-analysis of genome-wide association results from 2 independent discovery cohorts.  
A, The results for the arteriolar tortuosity (TortA) and (B) represents the results for the venular tortuosity trait (TortV). The blue and red horizontal 
lines indicate the suggestive and genome-wide significance threshold (P<5×10−8), respectively.
Figure 3. Regional association and recombination plots of variants that reached P value <5×10-7 in the meta-analysis of the 2 
discovery study cohorts (GoDARTS and ORCADES).  
A, Lead SNP for TortA; B, lead SNP for TortV. Each plot was created using LocusZoom for the lead single-nucleotide polymorphism (SNP) in 
genomic region 400 kb in either side of the significant signal. Blue spikes represent the estimated recombination rates. Color scale (high to 
low r2) circles depicts the pairwise correlation (r2) between lead SNP and other SNPs in the loci. The lead SNP in that region is indicated by 
purple color solid diamond, and gene annotations in this region are shown in the bottom. GoDARTS indicates Genetics of Diabetes Audit and 
Research in Tayside; and ORCADES, Orkney Complex Disease Study. 
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Table. Results of Discovery, Replication, and Overall Meta-Analysis for Tortuosity Traits
SNP Chromosome BP Candidate Gene EA (Frequency) Cohort β SE P Value
Heterogeneity  
P (I2)
TortA
rs7991229 13 111091995 COL4A2 G (0.42) GODARTS 0.136 0.032 2.30×10−05  
ORCADES 0.187 0.055 0.000728  
Stage 1 0.098* 0.018* 1.07×10−07† 0.75 (0)
LBC1936 0.029 0.014 0.039721  
All croatia 0.037 0.009 9.83×10−05  
Stage 2 0.114* 0.027* 2.80×10−05† 0.62 (0)
Combined 0.103* 0.015* 4.66×10−12† 0.65 (0)
rs9515212 13 111087563 COL4A2 G (0.42) GODARTS 0.138 0.032 1.96×10−05  
ORCADES 0.189 0.055 0.000685  
Stage 1 0.099* 0.018* 8.59×10−08† 0.75 (0)
LBC1936 0.029 0.014 0.043685  
All croatia 0.038 0.009 8.40×10−05  
Stage 2 0.114* 0.027* 2.01×10−05† 0.59 (0)
Combined 0.104* 0.015* 4.71×10−12† 0.85 (0)
rs56399312 13 111121981 COL4A2 C (0.27) GODARTS 0.186 0.037 6.67×10−07  
ORCADES 0.168 0.066 0.010473  
Stage 1 0.099* 0.018* 2.70×10−08† 0.15 (0.5)
LBC1936 0.025 0.018 0.17722  
All croatia 0.025 0.012 0.0386  
Stage 2 0.065* 0.027* 0.0149† 0.98 (0)
Combined 0.088* 0.015* 1.95×10−07† 0.07 (0.6)
TortV
rs1808382 19 39151034 ACTN4 T (0.47) GODARTS −0.125 0.026 2.41×10−06  
ORCADES −0.116 0.039 0.0031218  
Stage 1 −0.101* 0.018* 1.55×10−08† 0.69 (0)
LBC1936 −0.049 0.014 0.00065  
All croatia −0.033 0.009 0.00064  
Stage 2 −0.129* 0.027* 1.35×10−06† 0.87 (0)
Combined −0.109* 0.015* 2.39×10−13† 0.61 (0)
rs3786835 19 111087563 ACTN4 A (0.47) GODARTS −0.126 0.026 1.95×10−06  
ORCADES −0.109 0.039 0.004924  
Stage 1 −0.099* 0.018* 2.26×10−08† 0.87 (0)
LBC1936 −0.049 0.014 0.000537  
All croatia −0.033 0.009 0.0006  
Stage 2 −0.130* 0.027* 1.10×10−06† 0.84 (0)
Combined −0.109* 0.015* 3.31×10−13† 0.53 (0)
rs73157566 12 129533847 TMEM132D A (0.04) GODARTS −0.289 0.061 3.28×10−06  
ORCADES −0.314 0.113 0.005458  
Stage 1 −0.097* 0.018* 4.07×10−08† 0.28 (0.1)
LBC1936 −0.061 0.045 0.17165  
All croatia −0.003 0.029 0.9045  
Stage 2 −0.027* 0.027* 0.30795 0.35 (0)
Combined −0.075* 0.015* 2.61×10−06† 0.08 (0.6)
Natural log-transformed—TortA and TortV. BP indicates base position; Croatia, Croatia island of Korcula+Croatia-Split; EA, effect allele; GoDARTS, Genetics of Dia-
betes Audit and Research in Tayside; LBC1936, Lothian Birth Cohort 1936; ORCADES, Orkney Complex Disease Study; TortA, retinal arteriolar tortuosity; and TortV, 
retinal venular tortuosity.
*Standardized β (s.d.) estimate (Cohen d) and SE_β values. β, change in natural log-transformed retinal tortuosity traits for each copy of the effect allele; SE; base 
position is based on build 37 of the reference genome.
†Significant P value <0.05 in Stage 1, Stage 2, and combined.
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significant associations. Although TortA-associated 
SNPs, rs9515212 and rs7991229, were not genome-
wide significant in the discovery meta-analysis, they 
reached genome-wide significance in the overall meta-
analysis, and no heterogeneity (I2=0.00) was observed 
across different cohorts; Poverall=4.66×10
−12 and Pover-
all=4.71×10
−12, respectively. The lead SNP in COL4A2 
for TortA (rs56399312) at the discovery stage did not 
reach genome-wide significance in the overall meta-
analysis (Poverall=1.95×10
−07), suggesting it is not likely 
to be the causal association at this locus that warrants 
further study. For TortV the lead SNPs, rs1808382 (Pover-
all=2.39×10
−13) and rs3786835 (Poverall=3.31×10
−13) 
near ACTN4/CAPN12, increased genome-wide signifi-
cance and show no heterogeneity of effect sizes across 
studies (I2=0.00; Table). These SNPs are in tight linkage 
disequilibrium and, therefore, do not represent indepen-
dent signals. The effect estimates from each of the indi-
vidual study cohorts were standardized using Cohen d. 
Forest plots for lead SNPs in the combined analysis are 
shown in Figure 4.
Functional Annotation: TortA-Associated 
Variants
COL4A2 encodes collagen alpha-2(IV) (collagen type IV 
α 2), one of the 6 subunits of type IV collagens which 
are major structural components of basement mem-
branes, forming a thin sheet of fibers under the endothe-
lium controlling passage of vasoactive substances. These 
are conserved across species and C-terminal noncol-
lagenous domains play a role in angiogenesis.49 Recent 
GWAS report that common variants around COL4A2 and 
COL4A1 (a paralogue immediately proximal to COL4A2, 
with which it shares a promoter and is co-expressed), 
are associated with coronary artery calcification,50 arte-
rial stiffness,51 and CAD.29–31,52 Gene expression data 
from GeneAtlas,53 a human protein-coding transcriptome 
study validated the high expression of COL4A2 in retinal 
microvessel endothelial cells (Figure VI in the online-only 
Data Supplement) whereas COL4A1 is weakly expressed 
in retina indicating a specific role of COL4A2 in the reti-
nal vasculature. TortA-associated variants near COL4A2 
significantly alter transcription factor binding motifs and 
have putative effects on transcription as annotated by 
ENCODE (Table VI in the online-only Data Supplement). 
Additionally, expression data from the GTEx database34 
confirmed that these significant SNPs are associated with 
the expression of COL4A2 in heart left ventricle and artery 
aorta, shown in Table VII and Figure VII in the online-only 
Data Supplement, and these SNPs are in linkage disequi-
librium (rs9515212 and rs7991229; r2=0.99, D′=1).
Association of TortA-Associated Variants With 
Cardiovascular Risk Factors
Lead SNPs associated with TortA remained signifi-
cant after conditioning on the previously reported car-
diovascular risk variants in COL4A2 (rs11617955,29 
rs4773144,30 and rs951520331; Figure VIII and Table 
VIII in the online-only Data Supplement). Conversely, the 
lead SNPs for TortA were not associated with CAD and 
myocardial infarction risk in the Coronary Artery Disease 
Genome-wide Replication and meta-analysis plus C4D 
consortium meta-analysis29 (Table IX in the online-only 
Data Supplement). Finally, the CAD-associated variants 
specifically in COL4A1 from Coronary Artery Disease 
Genome-wide Replication and meta-analysis plus C4D 
were not associated with TortA, whereas CAD-associ-
ated COL4A2 variants are only weakly associated with 
TortA (Table X in the online-only Data Supplement). Reti-
nal arteriolar tortuosity traits have been previously asso-
ciated with blood pressure,10,12 which may, therefore, link 
these variants with CAD; however, we found no evidence 
for an association between these lead variants and blood 
pressure in the International consortium for blood pres-
sure GWAS analysis41 (Table XI in the online-only Data 
Supplement).
Figure 4. Forest plots for the genome-wide significant hits 
in overall meta-analysis. A, rs7991229 for TortA; B, rs1808382 
for TortV. The plots represent standardized β (βsd) and SE from 
GoDARTS (Genetics of Diabetes Audit and Research in Tayside), 
ORCADES (Orkney Complex Disease Study), LBC1936 (Lothian 
Birth Cohorts 1936), Croatia-Korcula Split, and meta-analysis study. 
Standardized β estimate: change in natural log-transformed retinal 
tortuosity traits for each copy of the effect allele.
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Functional Annotation: TortV-Associated 
Variants
ACTN4 encodes α-actinin 4 (alpha-actinin-4), a cross-
linking protein belonging to the spectrin superfamily and 
mutations in this gene cause focal segmental glomerulo-
sclerosis in humans. ACTN2, a homolog of ACTN4, inter-
acts with ACTN4 and missense mutations in ACTN2 are 
linked to a range of cardiac diseases.54 Annotation by 
ENCODE33 indicates that the 2 genome-wide significant 
variants (rs1808382 and rs3786835) associated with 
TortV near ACTN4 may have direct regulatory effects as 
they are located within a DNase I hypersensitivity site 
and in genomic regions enriched for promoter/enhancer 
histone marks in heart tissues (Table VI in the online-
only Data Supplement). ACTN4 and CAPN12 (calcium-
activated neural proteases 12) overlap by 339 bases at 
their 3′ ends and multitissue expression quantitative trait 
loci (eQTL) analysis confirms that these SNPs in ACTN4 
are associated with mRNA expression of both ACTN4 
and CAPN12 in aorta, tibial artery, atrial appendage, and 
left ventricle of the heart (Table VII and Figure IX in the 
online-only Data Supplement). Additionally, this analysis 
indicates that the T allele at rs1808382 is correlated 
with lower ACTN4 (artery aorta; P=2.1×10−03) and this 
correlation is even stronger with CAPN12 (artery aorta; 
P=2.0×10−07). Whereas gene expression data using 
Genevestigator validated the high expression of ACTN4 
in arterial tissue, the highest expression of CAPN12 
appears to be in the hematopoietic system.
Colocalization Analysis of SNPs in 
ACTN4/CAPN12
We further conducted eQTL/trait colocalization analyses 
with eCAVIAR45 and estimated the colocalization posterior 
probability for the lead variants that are associated with 
TortV and eQTLs. We found that the CAPN12 has sub-
stantially higher colocalization posterior probability in heart 
left ventricle and artery tibial tissues than the ACNT4 which 
indicates moderate colocalization between CAPN12 eQTL 
and TortV (Table XIII in the online-only Data Supplement). 
The heart left ventricle is considered as the most rele-
vant tissue (colocalization posterior probability; 0.38) for 
the TortV-associated lead variant (rs1808382)-CAPN12 
eQTL whereas for the other 3 tissues (heart atrial append-
age; 0.22, artery aorta; 0.27, and artery tibial; 0.37) are 
considered as the relevant tissues for the second top vari-
ant (rs3786835) associated with TortV-CAPN12 eQTL 
(Table XIII in the online-only Data Supplement).
Association of TortV-Associated Variants With 
Cardiovascular Risk Factors
Lead SNPs in ACTN4 were significantly associated 
with CAD in the Coronary Artery Disease Genome-wide 
Replication and meta-analysis plus C4D consortium 
meta-analysis29 (Table IX in the online-only Data Supple-
ment) and were associated with CAD risk factors include 
HDL (high-density lipoprotein) cholesterol and triglycer-
ides in the Global Lipid Genetics Consortium analysis40 
but not associated with LDL (low-density lipoprotein) 
cholesterol in the Global Lipid Genetics Consortium 
analysis or blood pressure in the International Consor-
tium for blood pressure GWAS analysis41 (Table XI in 
the online-only Data Supplement). Furthermore, we have 
confirmed the association between TortV and top vari-
ants in ACTN4/CAPN12 in a sensitivity analysis that only 
included GoDARTS samples without any cardiovascular 
events before the retinal screening date (Table XII in the 
online-only Data Supplement). Moreover, a recent meta-
analysis of 35 GWAS studies reported the association of 
SNP (rs11083475) in the ACTN4 locus with increased 
resting heart rate,42 which may increase cardiovascular 
disease risk. This signal appears the same as that for 
TortV with strong linkage disequilibrium being observed 
between the lead SNPs for TortV and the index SNP for 
heart rate. Furthermore, we found that these SNPs were 
associated with heart rate in UK Biobank43 (Table XIV 
and Figure X in the online-only Data Supplement). Inter-
estingly, TortV-associated SNPs also associated with AF 
in the recent AF GWAS analysis44 (Table XI in the online-
only Data Supplement).
DISCUSSION
In this first GWAS meta-analysis for quantitative retinal 
vascular tortuosity traits, we identify a novel locus for reti-
nal arteriolar tortuosity (COL4A2) and for retinal venular 
tortuosity (ACTN4/CAPN12), which were firmly estab-
lished by replication in 3 independent cohorts. Power 
calculations indicated that a sample size of 4507 (stage 
1 and stage 2), and 3094 (stage 1) and the effect size 
of 0.10 using Bonferroni correction (P<5×10−8) was 
adequate to provide 80% statistical power to detect the 
associations. Notably, we also identified in the discov-
ery studies a genome-wide significant signal at a previ-
ously reported locus in/near ATOH7/PBLD for the optic 
disc radius and replicated previously identified variants 
for CRVE which validate our retinal traits measurement 
methods. However, we did not replicate the previously 
reported SNPs for CRAE, but the direction of the effect 
was consistent. This may due to differences in the phe-
notyping, smaller effect sizes for certain SNPs compared 
to the previous studies and need for more power to rep-
licate this association (Table XV in the online-only Data 
Supplement).15,16
There are few limitations in this study. The meta-anal-
ysis of the lead SNPs for TortA and TortV in the replica-
tion cohorts (stage 2) lacks genome-wide significant P 
values which may due to the limited sample sizes. Other 
possible limitation of this study is that the retinal vascular 
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traits were measured using different software in the 
discovery (eg, Vascular Assessment and Measurement 
Platform for Images of Retina) and replication cohorts 
(eg, SIVA). In spite of this limitation, our findings show 
consistent, homogeneous effects on tortuosity across 
5 fairly diverse cohorts of European ancestry compris-
ing individuals with and without diabetes. This highlights 
the robust nature of these genetic effects on retinal vas-
cular topology. Also, these aspects strongly support the 
robustness our study design and findings.
Previous studies have reported association between 
COL4A2 and CAD but the TortA-associated variants in 
COL4A2 in the present study are not associated with car-
diovascular disease and similarly COL4A2 variants that 
are associated with CAD do not appear to be associ-
ated with arteriolar tortuosity suggesting that variants in 
this gene complex may be involved differentially in the 
pathophysiology of microvascular and macrovascular dis-
eases. However, more work has to be done to determine 
the distinct role of genetic variants in COL4A2/COL4A1 
in different clinical conditions. In contrast, we found 
that retinal venular tortuosity-associated variants near 
ACTN4/CAPN12 were associated with CAD, heart rate, 
and AF. Furthermore, the lead variant influences the 
expression of the ACTN4/CAPN12 genes in the heart 
and blood vessel tissues. But our colocalization eQTL 
analysis found CAPN12 as the most likely causal gene at 
the chromosome 19 locus. Our sensitivity analyses includ-
ing samples without CAD before the date of acquisition of 
the measured retinal image indicates that the relationship 
between genetic predictors of retinal venular tortuosity 
and cardiovascular diseases is not due to reverse causa-
tion and demonstrate the robustness of our findings.
Notably, the TortV-associated variants have shared 
genetic architecture with other cardiovascular-related 
traits including HDL cholesterol and AF. A recent study 
reported the relationship between retinal venular tor-
tuosity and lower HDL cholesterol in the Asian-based 
cross-sectional cohorts.12 Our in-silico look-ups indicate 
that the genetic determinants for TortV near ACTN4 
also associated with HDLC in the Global Lipid Genetics 
Consortium analysis GWAS but not associated with the 
LDLC which is consistent with the Asian-based study.12 A 
study from the ORCADES and Croatia-Korcula cohorts 
reported a weak association between retinal arteriolar 
tortuosity and systolic blood pressure and no signifi-
cant association between retinal venular tortuosity trait 
and blood pressure.10 A recent larger epidemiological 
study in European-based prospective cohort reported an 
association with systolic blood pressure for TortA, and a 
weaker association for TortV.55 In this regard, neither the 
TortA nor TortV-associated variants were associated with 
systolic and diastolic blood pressure in the International 
Consortium for blood pressure GWAS analysis; therefore, 
it seems unlikely that observed associations with CAD or 
related traits are mediated through blood pressure.
In summary, this first GWAS for retinal arteriolar and 
venular tortuosity reveals associated SNPs of strong 
effects influencing the expression of COL4A2 and 
ACTN4/CAPN12, respectively. Our results demonstrate 
that the TortA-associated variants in COL4A2 are inde-
pendent of CAD, myocardial infarction, and blood pres-
sure, and point to a selective role of COL4A2 rather 
than COL4A1 in the retinal vessels. Strikingly, we found 
TortV-associated ACTN4/CAPN12 SNPs are associated 
with CAD, HDL cholesterol, AF, and heart rate but not 
associated with blood pressure. Our findings appear to 
indicate CAPN12 as the causal gene for TortV through 
colocalization analysis. However, detailed investigation 
and functional validation of this new finding are essential 
to elucidate the causal role of this locus and the relative 
contribution of ACTN4 and CAPN12 in the observed car-
diovascular pathophysiology. These findings highlight the 
potential genetic impacts of retinal vasculature to provide 
new insights into cardiovascular disease.
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